10/29/2026
Day 2 of the 2026 NCODA International Fall Summit kicked off with a morning focused on innovation, emerging therapies, and advancing patient-centered oncology care.
We began with an inspiring keynote from Liz Forkin Bohannon of Sseko Designs, who shared insights on the power of human connection, building stronger relationships, and finding purpose in our personal and professional lives.
The morning continued with a look at the future of antibody-drug conjugates (ADCs), as Gad Chahoud, MD, MPH-MHA (Orlando Health), explored emerging developments and how oncology practices can prepare for what's ahead.
The focus then shifted to the evolving multiple myeloma treatment landscape, with Andrew Cowan, MD (BC Cancer), Elizabeth Rauschenberg, MSN, APRN, FNP-C (Maryland Oncology Hematology), and Attaya Suvannasankha, MD (Indiana University Health), discussing bispecifics, CAR-T therapies, and CELMoDs.
The next session highlighted the importance of translating education into practice through lessons from the NCODA BTCE Mentorship Program. Moderated by Kelly Brunk, PharmD, MBA, BCOP (NCODA), the session featured insights from Brooke Adams, PharmD, BCOP (Orlando Health), Kristen Eblen, PharmD (Lake Regional Health System), and Dhaval Patel, PharmD, BCOP (Karmanos Cancer Institute).
Poster presentations also allowed attendees to explore new research, exchange ideas, and connect with colleagues on innovative approaches to improving oncology care.
We're looking forward to continuing the conversations, sharing insights, and connecting with members and partners throughout the rest of the Summit!